Case series: CYP Inhibition and low dose ibrutinib for steroid‐refractory chronic graft‐versus‐host disease.

MLA

De, la Garza‐Salazar, Fernando, et al. “Case Series: CYP Inhibition and Low Dose Ibrutinib for Steroid‐refractory Chronic Graft‐versus‐host Disease.” British Journal of Haematology, vol. 201, no. 3, May 2023, pp. 573–76. EBSCOhost, https://doi.org/10.1111/bjh.18712.

APA

De, la G. F., Colunga, P. P. R., Coronado, A. E. U., Gutiérrez, A. C. H., Cantú, R. O. G., & Gómez, A. D. (2023). Case series: CYP Inhibition and low dose ibrutinib for steroid‐refractory chronic graft‐versus‐host disease. British Journal of Haematology, 201(3), 573–576. https://doi.org/10.1111/bjh.18712

Chicago

De, la Garza‐Salazar, Fernando, Pedraza, Perla Rocío Colunga, Alejandro, Edgar Ulises Coronado, Aguirre, César Homero Gutiérrez, Rodríguez, Olga Graciela Cantú, and Almaguer, David Gómez. 2023. “Case Series: CYP Inhibition and Low Dose Ibrutinib for Steroid‐refractory Chronic Graft‐versus‐host Disease.” British Journal of Haematology 201 (3): 573–76. doi:10.1111/bjh.18712.